Director, Data and Science (Analytic Solutions)
Verana HealthFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
Dianthus Therapeutics is a publicly traded, clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.
As the Associate Director or Director, Biostatistics you will lead critical statistical activities across one of our phase III clinical programs. Reporting to the Head of Biostatistics, you will provide strategic and technical leadership in the design, analysis, and interpretation of clinical trials in a dynamic, fast-paced organization. You will collaborate cross-functionally with Clinical Development, Clinical Operations, Regulatory, Data Management, Medical Writing, and external vendors to ensure the delivery of high-quality and compliant statistical deliverables. This is an exciting opportunity to join a growing team with ongoing phase III development and multiple streams of regulatory agency interactions. This role has direct visibility across Dianthus Therapeutics, including to senior leadership. We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients’ lives. We are open to you working remotely.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.